Table of Contents Table of Contents
Previous Page  176 / 490 Next Page
Information
Show Menu
Previous Page 176 / 490 Next Page
Page Background

174

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

POSTERS AND ELECTRONIC POSTERS

| PROGRAMME AND EXHIBITION GUIDE

POSTERS

> QoL after postoperative IMRT for cervical cancer: results from matched

pair analysis with 3DCRT

S. Chopra (India), S. Mohanty, U. Mahantshetty, S. Kannan, R. Engineer,

S. Mechanery, R. Phurailatpam, J. Ghosh, S. Gupta, S. Shrivastava

PO-0730

> Quality of life of women after endometrial cancer: the role of the vaginal

dilator

R. Foerster (Germany), L. Schnetzke, T. Bruckner, H. Rief, J. Debus,

K. Lindel

PO-0731

> Predictive factors for inter-fraction uterine motion in definitive

radiotherapy for cervical cancer

H. Maemoto (Japan), T.T. Takafumi Toita, S.H. Seiji Hashimoto,

T.A. Takuro Ariga, Y.K. Yasumasa Kakinohana, J.H. Joichi Heianna,

S.M. Sadayuki Murayama

PO-0732

> Treatment response evaluation with ADCmean in cervical cancer

patient treated with chemoradiotherapy

C. Onal (Turkey), G. Erbay, O.C. Guler

PO-0733

> Just in the prevention of radio-induced vaginal mucositis

F. Piccolo (Italy), A. Romano, A. Rese, E. D’Ippolito, F. Pastore,

P. Romanelli, L. Faraci, E. Toska, V. De Chiara, A. Farella, R. Solla,

M. Conson, R. Liuzzi, L. Cella, R. Pacelli

PO-0734

> Prognostic value of microRNA-205 in endometrial cancer patients

treated with adjuvant radiotherapy

M. Wilczynski (Poland), J. Danielska, J. Fijuth, A. Malinowski

PO-0735

Poster

CLINICAL TRACK: PROSTATE

> Tumour staging using MRI in prostate cancer: improvement of

treatment decisions for radiotherapy

F. Couñago (Spain), E. Del Cerro, A.A. Díaz-Gavela, F.J. Marcos, M. Recio,

D. Sanz-Rosa, I. Thuissard, K. Olaciregui, J. Castro-Novais, J. Carrascoso,

C. Hayoun, R. Murillo, J.M. Rodriguez-Luna, C. Bueno, J. Hornedo,

R. Perez-Carrion, V. Martinez de Vega, M. Mateo

PO-0736

> Predictors of PSA relapse in patients with intermediate risk prostate

cancer treated with SBRT

T. Kole (USA), S. Guleria, H. Koneru, O. Obayomi-Davies, T. Yung, S. Lei,

B. Collins, S. Suy, A. Dritschilo, S. Collins

PO-0737